Zevalin With Non Myeloablative Allogeneic Stem Cell Transplantation in Patients With Non Hodgkin Lymphoma

NCT00807196 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Non-Hodgkins Lymphoma

Interventions

DRUG: Rituximab
DRUG: 90Y ibritumomab tiuxetan (Zevalin)
DRUG: Cyclophosphamide
DRUG: Fludarabine
OTHER: Non myeloablative allogeneic stem cell transplantation

Sponsor

Maisonneuve-Rosemont Hospital

Collaborators

[object Object]